Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Salbutamol sulfate
Apotex Pty Ltd
Medicine Registered
GENRX SALBUTAMOL INHALATION AMPOULE 1 GENRX SALBUTAMOL INHALATION AMPOULES _Contains the active ingredient salbutamol (sal-bew-tam-ol) sulphate _ CONSUMER MEDICINE INFORMATION _FOR A COPY OF A LARGE PRINT LEAFLET, PH: 1800 195 055 _ WHAT YOU NEED TO KNOW ABOUT GENRX SALBUTAMOL INHALATION AMPOULES Your doctor has weighed the risks and expected benefits of salbutamol and decided to prescribe this medicine to help treat your condition, or the condition of someone you are caring for. Read this leaflet carefully before you start to take this medicine. It contains important information. KEEP THE LEAFLET IN A SAFE PLACE BECAUSE YOU MAY WANT TO READ IT AGAIN. If you have any other questions, or if there is something you don't understand please ask your doctor or pharmacist for advice. Pharmaceutical companies cannot give you medical advice or an individual diagnosis. This medicine has been prescribed for you. You should never give it to anyone else. It may not be the right medicine for them even if their symptoms seem to be the same as yours. If you develop any side effects that are serious or if you notice any side effects that are not listed in this leaflet, tell your doctor or pharmacist immediately or go to the nearest hospital. Also look at Section 4: "Possible side effects". This medicine is only part of a general plan to help you to manage your asthma or other breathing conditions. You should discuss this plan with your doctor. Ask your doctor to check your treatment plan regularly. _WHAT IS IN THIS LEAFLET _ 1. WHAT GENRX SALBUTAMOL INHALATION AMPOULES ARE FOR 2. THINGS TO CONSIDER BEFORE YOU USE GENRX SALBUTAMOL INHALATION AMPOULES 3. HOW TO USE THIS MEDICINE 4. POSSIBLE SIDE EFFECTS Read the complete document
Product Information – Australia GENRX SALBUTAMOL INHALATION AMPOULE Page 1 GENRX SALBUTAMOL INHALATION AMPOULE NAME OF THE MEDICINE Salbutamol sulfate. Chemical Name: di[(RS)-2-(1,1-dimethyl)ethylamino-1-[4-hydroxy-3- (hydroxymethyl)phenyl]ethanol] sulfate. Structural Formula: HO HO N OH H CH 3 CH 3 CH 3 2 . H 2 SO 4 Molecular Formula: (C 13 H 21 NO 3 ) 2 .H 2 SO 4 Molecular Weight: 576.7 CAS Registry Number: 51022-70-9 DESCRIPTION Salbutamol sulfate is a white or almost white, odourless powder with a slightly bitter taste. It is freely soluble in water; slightly soluble in alcohol, chloroform and ether, very slightly soluble in methylene chloride. Salbutamol sulfate 1.2 mg is approximately equivalent to 1 mg salbutamol. PHARMACOLOGY Salbutamol is a β 2 -adrenoreceptor agonist. PHARMACOKINETICS Absorption Following inhalation of salbutamol the onset of action is 5 to 15 minutes. Only 10 to 20% of the dose reaches the lungs, the remainder stays in the mouth, stomach or on the apparatus. Salbutamol reaching the lungs acts rapidly and directly on bronchial smooth muscle. Initially, the drug is undetectable in blood but after two to three hours, low concentrations are seen, due presumably to the portion of the dose which is swallowed and absorbed by the gut. Distribution Salbutamol is not bound to plasma proteins. Metabolism The major metabolite of salbutamol, recovered fr om urine, has been identified as the 4’-o-sulfate ester. This metabolite has negligible β-stimulant activity. Salbutamol is not metabolised in the lung and the pattern of metabolism and excretion (as well as absorption) suggest tha Read the complete document